Navigation Links
Spanish Government Selects Novavax's VLP Technology for Comprehensive Flu Vaccine Solution in Spain
Date:6/30/2009

ROCKVILLE, Md., June 30 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announced today its initial agreement to license its proprietary, recombinant virus-like-particle (VLP) vaccine technology to ROVI Pharmaceuticals (Madrid: ROVI) of Spain. ROVI will use the VLP technology to create a comprehensive influenza vaccine solution for the Spanish government under a new 60 million-euro program sponsored and led by the Spanish Ministry of Health and other government groups to develop pandemic and seasonal flu vaccines and establish its only in-border facility. This program, which was announced today by Spanish health officials, is being launched to develop safe and effective flu vaccines to serve the entire population of Spain.

Under separate agreements that are in the process of being negotiated by both companies, ROVI will receive exclusive licenses to Novavax's portable VLP vaccine technology to commercialize flu vaccines in Spain and Portugal, and non-exclusive licenses in Europe, Latin America and Africa. Furthermore, under a stock purchase agreement executed today, ROVI has committed to make a $3 million (US) equity investment in Novavax at $2.74 per share, a 10% premium to the June 29, 2009 closing bid price on the NASDAQ Global Market. A non-profit Foundation, jointly sponsored by ROVI and the Spanish authorities, will be formed and initially funded with a 25 million euro credit line from the Spanish government, to support Phase III clinical development and other studies necessary to achieve marketing authorization of the VLP influenza vaccines in the European Union in 2012. Additional clinical development funds will be contributed by ROVI if required. In addition, the State of Andalucia will support ROVI in building a new VLP vaccine plant in the city of Granada and bring it on-line in 2012 at a cost of approximately 20 million e
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. LMXonline Offers Spanish-Language Safety and Health Training Library
2. Spanish Research Consortium Signs Four-Year Renewal Deal for ISI Web of Knowledge
3. Government Mandates Create Guaranteed Market for Bio-Fuel, Says Frost & Sullivan
4. Sundias Animal Facility Passed Client and Government Inspection
5. PTC Therapeutics Receives $2.6 Million in Government Grants
6. Neogen Partners With Chinese Government
7. GeneNews to conduct joint project funded by MYR 5 million grant from Malaysian government
8. Quest Diagnostics Finalizes Previously Announced Settlement With Government Related to Test Kit Subsidiary Closed in 2006
9. Canadian Government Announces Funding for Leading Biotechnology Firms Project
10. Mental Stimulus Package: Government Officials who Forgot to Pay Taxes Will Receive Free Memory-boosting Supplement
11. Modigene Awarded Second-Year Grant by Israeli Government to Support Development of Its Longer-Acting Human Growth Hormone

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,Ontario,Nov.24/PRNewswire-FirstCall/--DowAgroScie...landSeeds,adivisionofThompsonsLimitedofBlenheim,On...AgroSciences,currentseedsbusinessasthecompanyantic...dDowAgroSciencesHerbicideTolerantTraitTechnologyin...rfuture. ,, "Thisacquisitionbringstogethertwost...
(Date:11/24/2009)... Health care employment grew by 29,000 jobs in Oc...consistent growth during the U.S. recession. Howev...ble, and health systems are coming closer to havin...st administrators. , (Voc...ntinued growing in October despite the shedding of...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq:...ngandcommercializingnovelpainmanagementtherapies,a...xecutiveOfficer,isscheduledtopresentatthe21stAnnua...1-2,2009atTheNewYorkPalaceHotelinNewYork,NewYork. ...Officer,willbeavailabletorespondtoquestionsduringt...
(Date:11/24/2009)...The FBI recently approved the Promega PowerPlex 16...n or generating DNA records for the National DNA I...I USA (PRWEB) -- The FBI recently approved the Pro...ratories participating in, or generating DNA recor... currently contains more than seven million profil...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...senting at BIO CEO & Investor Conference, LOUISVI... ) announced today that it will host a conference ... to report 2007 fourth quarter,and year-end earnin...oming,investor conference in February 2008., Ear... Kenneth J. Collins, President and CEO, and othe...
...SISSAUGA, ON, Feb. 5 /PRNewswire-FirstCall/ - Vaso... Company focused on the research and,commercial de...flammation,underlying cardiovascular and neurologi...resident and CEO, will present a Company Overview ...toria, New York City, at 11:00,a.m. (ET) on Tuesda...
...KVILLE, Md., Feb. 5 EntreMed, Inc.,(Nasdaq: ENMD...ing,therapeutics for the treatment of cancer and i.... Burns, President and Chief Executive Officer, wi... Investor Conference, to be,held at the Waldorf-As...ntation is scheduled for Tuesday, February 12, 200...
Other Biology Technology:Replidyne to Report 2007 Fourth Quarter and Year-End Earnings 2Replidyne to Report 2007 Fourth Quarter and Year-End Earnings 3Vasogen to Present at the BIO CEO & Investor Conference and Participate on the Non-Cancer Immunotherapy Panel 2Vasogen to Present at the BIO CEO & Investor Conference and Participate on the Non-Cancer Immunotherapy Panel 3EntreMed to Present at BIO CEO and Investor Conference 2
(Date:11/24/2009)...stallised a protein that may help gut bacteria bin... be used by probiotic producers to identify strain... , "Probiotics need to interact with cells lining...attach to surfaces in the gut they are more likely...ty," says Dr Nathalie Juge from the Institute of F...
(Date:11/24/2009)...erican College of Medical Toxicology (ACMT) have s...on of the Journal of Medical Toxicology (JMT), t...h 2010. It was previously published by the Univer...edical Toxicology , an international, peer-reviewe...nd practice of medical toxicology. The quarterly ...
(Date:11/24/2009)...ish food is a matter of debate. A high-profile stu...50 percent of their carbon from trees and leaves, ...rial and aquatic ecosystems. , But new research ...t likely to be true. Algae provide a much richer d...research published this week in the Proceedings o...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2Springer and the American College of Medical Toxicology to work together 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Terumo Heart Inc Wins Top Healthcare Category Honors at AnnArbor com 26apos 3Bs 5th Annual 26amp 3B 238216 3BDeals Of The Year 26apos 3B Award Cere 61603 1Terumo Heart Inc Wins Top Healthcare Category Honors at AnnArbor com 26apos 3Bs 5th Annual 26amp 3B 238216 3BDeals Of The Year 26apos 3B Award Cere 61603 2Terumo Heart Inc Wins Top Healthcare Category Honors at AnnArbor com 26apos 3Bs 5th Annual 26amp 3B 238216 3BDeals Of The Year 26apos 3B Award Cere 61603 3Community Health Officials Can Improve Real Time H1N1 Information Sharing with New Resources from Depiction Inc 61599 1Community Health Officials Can Improve Real Time H1N1 Information Sharing with New Resources from Depiction Inc 61599 2Community Health Officials Can Improve Real Time H1N1 Information Sharing with New Resources from Depiction Inc 61599 3Mainstay of the Global Workforce 40 65 Year Olds Hit Hardest by Chronic Obstructive Pulmonary Disease 28COPD 29 14894 1Mainstay of the Global Workforce 40 65 Year Olds Hit Hardest by Chronic Obstructive Pulmonary Disease 28COPD 29 14894 2Mainstay of the Global Workforce 40 65 Year Olds Hit Hardest by Chronic Obstructive Pulmonary Disease 28COPD 29 14894 3Mainstay of the Global Workforce 40 65 Year Olds Hit Hardest by Chronic Obstructive Pulmonary Disease 28COPD 29 14894 4
..., Nitrogen pollution from agriculture and fossil ... in the UK. A new European study is starting to sh... current policies to protect ecosystems may need a...in 2004, her findings were so significant they wer...elected as contributing to one of the top ten scie...
..., Athens, Ga. For the estimated millions of AIDS...oping resistance to currently available medicines,... may offer a new treatment option by targeting a p... responsible for the devastating disease. , Appr...ectious viral disease known as HIV-AIDS. Although ...
..., WALNUT CREEK, -The genome analysis of a tiny gr...uniquely associated with carbon dioxide capture an...es revealed in the study are those that encode the...le that houses the photosynthetic apparatus, the c...ght to chemical energy. The genome also provides ...
Other Biology News:Nitrogen -- the silent species eliminator 2Nitrogen -- the silent species eliminator 3New class of drug offers hope to treatment-resistant AIDS patients 2New class of drug offers hope to treatment-resistant AIDS patients 3Green alga genome project catalogs carbon capture machinery 2Green alga genome project catalogs carbon capture machinery 3
Sheep Anti-Pig Malate Dehydrogenase Polyclonal Antibody, Unconjugated from Abcam
TaqMan Rodent GAPDH Control Reagents from Applied Biosystems
Anti-Sodium Channel, NaB2 (B2 subunit of Voltate-Gated Na+ Channel, Scn2b) Polyclonal Antibody, Unconjugated from CHEMICON
Chicken Anti-HAGH Polyclonal Antibody, Unconjugated from Abcam
Biology Products: